Hirsutism: Diagnosis and Management

    April 2010 in “ Gender Medicine ”
    Lindsey A. Brodell, Mary Gail Mercurio
    Image of study
    TLDR The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.
    The document reviewed the condition of hirsutism, which is excessive hair growth in women, and its impact on quality of life. It discussed the various potential causes, including idiopathic hirsutism, functional ovarian hyperandrogenism, congenital adrenal hyperplasia, and Cushing's syndrome. The document noted that idiopathic hirsutism accounts for about half of mild cases. Diagnostic approaches include history taking, physical examination, and laboratory tests for serum testosterone and DHEAS levels. Treatment options range from oral contraceptives and antiandrogens to insulin-sensitizing agents, topical treatments, and physical hair removal methods. The document also mentioned the lack of evidence for complementary and alternative medicine treatments like saw palmetto. The importance of diagnosing hirsutism was emphasized due to its psychological effects and as an indicator of possible underlying health issues.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results

    Related Community Posts Join

    6 / 24 results

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  36 upvotes 5 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Does low HGH leading to hairloss?

      in Research/Science  13 upvotes 9 months ago
      The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

    Related Research

    3 / 3 results